Launched on World Pancreatic Cancer Day, the website aims to empower Latinos with resources and information to learn about the disease, and access to the latest science-driven treatment options. The new Spanish-language website mirrors the Let’s Win website in English with the same comprehensive sections focused on treatments, the latest research, clinical trials, and managing life during treatment.
According to a study by the Associated Press-NORC Center for Public Affairs Research, nearly “6 in 10 Latino adults have had a difficult time communicating with a health care provider because of a language or cultural barrier” which is why they look to outside sources.
Now in its third year, Let’s Win is expanding its efforts to focus on reaching underserved Black and Latino communities. The goal of the Spanish version of its website is to help fill the gap for patients and their families.
“Since launching Let’s Win three years ago, we have seen the impact the platform has had with patients, the medical community, and health advocates,” said Cindy Price Gavin, Founding Executive Director. “The launch of the Spanish-language platform, as we commemorate World Pancreatic Cancer Day, is part of our steadfast commitment to empower all communities in our country, including diverse and underserved groups, with the resources and information they need.”
Let’s Win works with world-renowned doctors and researchers to share information about innovative treatments and clinical trials that are helping patients live longer with pancreatic cancer. Through an interactive web platform and robust social media campaigns on Facebook, Twitter, and Instagram, Let’s Win is reaching out to all who are affected by pancreatic cancer to bring them the latest information about this disease.
The American Cancer Society states that in 2018, approximately 55,000 people will be diagnosed with pancreatic cancer and 44,000 people will die of the disease. Among Latinos, approximately 3,500 people will be diagnosed and 2,500 will die of the disease. Pancreatic cancer is on the rise and is poised to become the second-leading cause of cancer death in the US by 2020.